Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $1.2 billion.

  • Agilon Health's Total Non-Current Liabilities fell 1413.81% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 1413.81%. This contributed to the annual value of $1.2 billion for FY2024, which is 1757.82% up from last year.
  • Per Agilon Health's latest filing, its Total Non-Current Liabilities stood at $1.2 billion for Q3 2025, which was down 1413.81% from $1.2 billion recorded in Q2 2025.
  • Agilon Health's 5-year Total Non-Current Liabilities high stood at $1.6 billion for Q1 2024, and its period low was $400.4 million during Q4 2021.
  • For the 5-year period, Agilon Health's Total Non-Current Liabilities averaged around $978.3 million, with its median value being $1.0 billion (2023).
  • In the last 5 years, Agilon Health's Total Non-Current Liabilities surged by 11645.61% in 2023 and then crashed by 1413.81% in 2025.
  • Agilon Health's Total Non-Current Liabilities (Quarter) stood at $400.4 million in 2021, then skyrocketed by 43.46% to $574.4 million in 2022, then surged by 75.75% to $1.0 billion in 2023, then rose by 17.58% to $1.2 billion in 2024, then grew by 4.46% to $1.2 billion in 2025.
  • Its Total Non-Current Liabilities stands at $1.2 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.4 billion for Q1 2025.